CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Nov. 30, 2021	Nov. 30, 2021	Nov. 30, 2020	Aug. 31, 2021
Operating activities:
Net income		$ 18,555	$ 23,623
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		1,987	1,700
Net losses (gains) on sales and disposals of property and equipment		9	(55)
Deferred income taxes		738	236
Stock-based compensation		2,891	2,665
Unrealized foreign currency exchange losses		541	52
Provision for bad debts		30	124
Changes in assets and liabilities:
Trade and other accounts receivable		(7,980)	(9,936)
Inventories		(13,054)	(345)
Other assets		(1,793)	(1,304)
Operating lease assets and liabilities, net		2	6
Accounts payable and accrued liabilities		4,126	4,590
Accrued payroll and related expenses		(7,324)	624
Other long-term liabilities and income taxes payable		325	1,941
Net cash (used in) provided by operating activities		(947)	23,921
Investing activities:
Purchases of property and equipment		(2,434)	(3,812)
Proceeds from sales of property and equipment		72	142
Net cash used in investing activities		(2,362)	(3,670)
Financing activities:
Treasury stock purchases	$ (7,400)	(7,386)
Dividends paid		(9,905)	(9,199)
Proceeds from issuance of long-term senior notes			52,000
Repayments of long-term senior notes		(400)	(400)
Net repayments of revolving credit facility			(50,000)
Shares withheld to cover taxes upon conversions of equity awards		(4,246)	(3,490)
Net cash used in financing activities		(21,937)	(11,089)
Effect of exchange rate changes on cash and cash equivalents		(1,196)	220
Net (decrease) increase in cash and cash equivalents		(26,442)	9,382
Cash and cash equivalents at beginning of period		85,961	56,462	$ 56,462
Cash and cash equivalents at end of period	$ 59,519	59,519	65,844	$ 85,961
Supplemental disclosure of noncash investing activities:
Accrued capital expenditures		$ 294	$ 1,274